Valbiotis
https://www.valbiotis.com/en/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Valbiotis
Tech Transfer Roundup: Tiba And CEPI Strategize Together On ‘Disease X’
Immix collaborates with Israeli research institutions on BCMA-targeted CAR-T therapy. NeoImmuneTech/NIAID alliance could pave way for “animal rule” approval in acute radiation syndrome.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Nutraceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice